Skip to main content
TECH logo

Bio-Techne Corporation

TECHNASDAQHealthcareBiotechnology

$72.57Today:- (-)1Y +17.23%

As of Oct 16, 2026 close

Market cap
$11.39B
P/E (TTM)
62.61
Forward P/E
31.27
Dividend yield
1.45%
52-week range
$43.20$72.69
Volume (live)
-
Avg. volume (3M)
2.98M

Bio-Techne (TECH) Balance Sheet

As of Jun 30, 2026 (end of fiscal 2026), Bio-Techne reported total assets of $2.68B and total liabilities of $570.77M. Shareholders' equity was $2.11B, up 9.9% from $1.92B a year earlier. Total debt stood at $289.09M against $264.71M in cash and short-term investments, a net debt position of $24.38M. That puts debt-to-equity at 0.14, compared with 0.24 a year earlier.

Bio-Techne Balance Sheet Analysis

Values in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Bio-Techne Corporation (TECH) - Annual data in billions USD
BreakdownFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingJun 2026Jun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017
Current Assets
Cash and Cash Equivalents0.260.160.150.180.170.200.150.100.120.09
Short-Term Investments0.000.000.000.020.070.030.120.070.060.07
Cash & Short-Term Investments0.260.160.150.200.250.230.270.170.180.16
Accounts Receivable0.220.210.240.220.190.150.120.140.120.12
Inventory0.200.190.180.170.140.120.100.090.090.06
Other Current Assets0.060.050.040.030.020.020.020.020.010.01
Total Current Assets0.740.610.620.620.610.510.520.410.400.35
Non-Current Assets
Property, Plant & Equipment (Net)0.300.320.340.320.290.280.250.150.150.14
Long-Term Investments0.250.250.240.260.040.000.00-0.090.000.04
Goodwill0.980.980.970.870.820.840.730.730.600.58
Intangible Assets0.300.370.510.530.530.620.520.580.450.45
Other Non-Current Assets0.010.020.020.030.050.010.010.01-0.08-0.12
Total Non-Current Assets1.931.952.092.021.691.751.511.471.191.21
Total Assets2.682.562.702.642.292.262.031.881.591.56
Current Liabilities
Accounts Payable0.030.030.040.030.030.030.020.020.020.02
Short-Term Debt0.010.030.030.010.010.010.020.010.000.00
Current Portion of Long-Term Debt----0.010.01----
Accrued Liabilities0.080.090.070.050.080.07----
Deferred Revenue0.040.030.030.020.020.020.010.010.010.01
Other Current Liabilities0.090.080.060.060.030.010.050.060.050.11
Total Current Liabilities0.160.180.160.130.180.150.110.100.080.14
Non-Current Liabilities
Long-Term Debt0.270.430.410.440.240.330.410.490.340.34
Deferred Tax Liabilities0.110.010.060.090.100.090.100.090.090.12
Other Non-Current Liabilities0.020.030.010.010.120.140.030.030.010.13
Total Non-Current Liabilities0.410.460.480.540.420.540.540.620.440.47
Total Liabilities0.570.640.640.670.590.690.650.720.510.61
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.000.000.000.00
Retained Earnings1.141.071.331.311.121.091.060.930.880.80
Accumulated Other Comprehensive Income-0.07-0.06-0.08-0.07-0.08-0.06-0.10-0.08-0.04-0.05
Additional Paid-in Capital1.030.910.820.720.650.530.420.320.250.20
Minority Interest0.000.000.000.000.000.010.000.000.000.00
Shares Outstanding0.160.150.160.160.16-----
Total Stockholders' Equity2.111.922.071.971.701.571.381.171.080.95
Total Liabilities & Equity2.682.562.702.642.292.262.031.881.591.56

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Bio-Techne Balance Sheet

How much debt does Bio-Techne have?

Bio-Techne had total debt of $289.09M as of Jun 30, 2026, against $264.71M in cash and short-term investments. Its debt-to-equity ratio was 0.14. Total debt was $458.16M a year earlier.

What are Bio-Techne's total assets?

Bio-Techne reported total assets of $2.68B as of Jun 30, 2026, up 4.7% from $2.56B a year earlier. Total liabilities were $570.77M.

What is Bio-Techne's shareholders' equity?

Bio-Techne's shareholders' equity was $2.11B as of Jun 30, 2026, or about $13.51 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition